Industrializing AI-powered drug discovery: lessons learned from the Patrimony computing platform
Authors:
Open Access
- 10 July 2022
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 17 (8) , 815-824
Abstract
As a mid-size international pharmaceutical company, we initiated 4 years ago the launch of a dedicated high-throughput computing platform supporting drug discovery. The platform named ‘Patrimony’ w...Keywords
Funding Information
- Servier
This publication has 85 references indexed in Scilit:
- BLUEPRINT to decode the epigenetic signature written in bloodNature Biotechnology, 2012
- Molecular signatures database (MSigDB) 3.0Bioinformatics, 2011
- Network medicine: a network-based approach to human diseaseNature Reviews Genetics, 2010
- Modeling sample variables with an Experimental Factor OntologyBioinformatics, 2010
- BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinitiesNucleic Acids Research, 2006
- Literature mining for the biologist: from information retrieval to biological discoveryNature Reviews Genetics, 2006
- Inference in Bayesian networksNature Biotechnology, 2006
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- UniProt: the Universal Protein knowledgebaseNucleic Acids Research, 2004
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002